Systematic review and network meta-analysis of the efficacy of existing treatments for patients with recurrent glioblastoma.

Neuro-oncology Advances
Anna SchritzSusanne Schmitz

Abstract

Despite advances in the treatment of cancers over the last years, treatment options for patients with recurrent glioblastoma (rGBM) remain limited with poor outcomes. Many regimens have been investigated in clinical trials; however, there is a lack of knowledge on comparative effectiveness. The aim of this systematic review is to provide an overview of existing treatment strategies and to estimate the relative efficacy of these regimens in terms of progression-free survival (PFS) and overall survival (OS). We conducted a systematic review to identify randomized controlled trials (RCTs) investigating any treatment regimen in adult patients suffering from rGBM. Connected studies reporting at least one of our primary outcomes were included in a Bayesian network meta-analysis (NMA) estimating relative treatment effects. Forty RCTs fulfilled our inclusion criteria evaluating the efficacy of 38 drugs as mono- or combination therapy. Median OS ranged from 2.9 to 18.3 months; median PFS ranged from 0.7 to 6 months. We performed an NMA including 24 treatments that were connected within a large evidence network. Our NMA indicated improvement in PFS with most bevacizumab (BV)-based regimens compared to other regimens. We did not find any ...Continue Reading

References

Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Mar 27, 2002·International Journal of Epidemiology·Matthias EggerGeorge Davey Smith
Sep 28, 2004·Statistics in Medicine·G Lu, A E Ades
Oct 15, 2005·BMJ : British Medical Journal·Deborah M CaldwellJ P T Higgins
May 21, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen P JansenWiro Stam
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry S FriedmanTimothy Cloughesy
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickHoward A Fine
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K ParkPeter McL Black
Apr 6, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Eric T WongSteven Brem
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Apr 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Thierry GorliaMartin J van den Bent
Oct 8, 2013·PloS One·Anna ChaimaniGeorgia Salanti
Apr 23, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Linda DirvenUNKNOWN Dutch Neuro-Oncology Group (LWNO)
Jul 2, 2015·Neuro-oncology·Kathryn M FieldMark A Rosenthal
Sep 12, 2015·Future Oncology·Enrico FranceschiAlba A Brandes
Oct 16, 2015·Expert Review of Neurotherapeutics·Omar Abdel-Rahman, Mona Fouad
Aug 2, 2016·Journal of the Egyptian National Cancer Institute·Supriya MallickGoura K Rath
Apr 14, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A QaziS K Singh
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenEudocia Q Lee
Jul 22, 2017·Journal of Neuro-oncology·Myra E van LindeHenk M W Verheul
Dec 6, 2017·Journal of Neurosciences in Rural Practice·Anshu Gupta, Tanima Dwivedi
Dec 14, 2018·Journal of Neuro-oncology·Farasat KazmiBalamurugan Vellayappan
Oct 14, 2019·Current Oncology Reports·Caroline Chaul-Barbosa, Daniel Fernandes Marques
Jan 11, 2020·Frontiers in Immunology·Paula Dobosz, Tomasz Dzieciątkowski
Jul 1, 2020·Biometrical Journal. Biometrische Zeitschrift·Gerta RückerGuido Schwarzer
Nov 17, 2020·Surgical Neurology International·Sabrina Araujo de FrancaWellingson Silva Paiva

❮ Previous
Next ❯

Software Mentioned

R Studio
Adobe Acrobat Pro
R2WinBUGS
Microsoft Word
WINBUGS14
WebPlotDigitizer

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Mary Jane Lim FatWarren P Mason
Current Oncology Reports
Caroline Chaul-Barbosa, Daniel Fernandes Marques
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Sagun ParakhHui K Gan
© 2021 Meta ULC. All rights reserved